Angiogenesis in portal hypertension: Involvement in increased splanchnic blood flow and collaterals?

Acta Clinica Belgica

Volumn 62, Issue 5, 2007, Pages 271-275

  Geerts, A M ^a   Colle, I ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Angiogenesis; Portal hypertension; Vascular endothelial growth factor

Indexed keywords

PLACENTAL GROWTH FACTOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN;

ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; CIRCULATION; EDITORIAL; ENDOTHELIUM CELL; HUMAN; MICROCIRCULATION; MORBIDITY; MORTALITY; PORTAL HYPERTENSION; SPLANCHNIC BLOOD FLOW; VASODILATATION;

EID: 37149039425     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2007.042     Document Type: Editorial

References (25)

1. Bosch J, Garcia-Pagan JC. Complications of cirrhosis. I. Portal hypertension. J Hepatol 2000; 32: 141-56.
2. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2006; 6: 389-95.
3. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653-60.
4. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-76.
5. Carmeliet P, Moons L, Luttun A et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7: 575-83.
6. Autiero M, Waltenberger J, Communi D et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 2003; 9: 936-43.
7. Wiest R, Shah V, Sessa WC, Groszmann RJ. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am J Physiol 1999; 276: G1043-51.
8. Iwakiri Y, Tsai MH, McCabe TJ et al. Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension. Am J Physiol Heart Circ Physiol 2002; 282: H2084-90.
9. Fukumura D, Gohongi T, Kadambi A et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. PNAS 2001; 98: 2604-09.
10. Garcia-Cardena G, Fan R, Shah V et al. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 1998; 392: 821-4.
11. Abraldes JG, Iwakiri Y, Loureiro ML, Haq O, Sessa WC, Groszmann RJ. Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state. Am J Physiol Castrointest Liver Physiol 2006; 290: 980-7.
12. Sumanovski LT, Battegay E, Stumm M, van der Kooij M, Sieber CC. Increased angiogenesis in portal hypertensive rats: role of nitric oxide. Hepatology 1999; 29: 1044-9.
13. Sieber CC, Sumanovski LT, Stumm M, van der Kooij M, Battegay E. In vivo angiogenesis in normal and portal hypertensive rats: role of basic fibroblast growth factor and nitric oxide. J Hepatol 2001; 34: 644-50.
14. Cejudo-Martin P, Ros J, Navasa M et al. Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2001; 34: 487-93.
15. Perez-Ruiz M, Ros J, Morals-Ruiz M et al. Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide. Hepatology 1999; 29: 1057-63.
16. Geerts AM, De Vriese AS, Vanheule E et al. Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study. Liver Int 2006; 26: 889-98.
17. Fernandez M, Vizzutti F, Garcia-Pagan JC, Rodes J, Bosch J. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. Gastroenterology 2004; 126: 886-94.
18. Fernandez M, Mejias M, Angermayr B, Garcia-Pagan JC, Rodes J, Bosch J. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. J Hepatol 2005; 43: 98-103.
19. Angermayr B, Fernandez M, Mejias M, Gracia-Sancho, Garcia-Pagan JC, Bosch J. NAD(P)H oxidase modulates angiogenesis and development of porto-systemic collaterals and splanchnic hyperaemia in portal hypertensive rats. Gut 2007; 56: 560-4.
20. Angermayr B, Mejias M, Gracia-Sancho J, Garcia-Pagan JC, Bosch J, Fernandez M. Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats. J Hepatol 2006; 44: 1033-9.
21. Fernandez M, Bonkovsky HL. Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats. Hepatology 1999; 29: 1672-9.
22. Geerts AM, Vanheule E, Carmeliet P et al. The role of placental growth factor in the mesenteric neo-angiogenesis of portal hypertensive mice. Award of the Young Investigators, Belgian Congress of Internal Medicine, 2006, 1 Dec. Brussels, Belgium (oral presentation). Abstract published: Act Clin Belg 2006; 61: 298.
23. Tsugawa K, Hashizume M, Tomikawa M et al. Immunohistochemical localization of vascular endothelial growth factor in the rat portal hypertensive gastropathy. J Gastroenterol Hepatol 2001; 16: 429-37.
24. Tsugawa K, Hashizume M, Migou S et al. Role of vascular endothelial growth factor in portal hypertensive gastropathy. Digestion 2000; 61: 98-106.
25. Yin ZH, Liu XY, Huang RL, Ren SP. Expression of TNF-α and VEGF in the esophagus of portal hypertensive rats. World J Gastroenterol 2005; 11: 1232-6.